PADI6 and Early Embryo Arrest: A Maternal-Effect Gene Explained

One of the most painful patterns in IVF is embryos that fertilize normally and then simply stop — arresting after a few divisions, again and again, with no clear reason. For a specific group of people, part of that pattern traces back to a maternal-effect gene called PADI6.

PADI6 is not a household name, and it is a rare cause. But it is one of the clearest examples of why a chromosome test can look normal while something more fundamental is going wrong in the earliest hours of development.

The handoff every embryo has to make

For the first few days after fertilization, an embryo runs almost entirely on supplies the egg packed in advance — maternal proteins and RNA, loaded during egg development. Then it has to make a critical handoff called embryonic genome activation: the embryo switches on its own DNA and takes over from the maternal supplies. If that handoff fails, development stops. This is a common point of very early arrest.

Managing that transition is the job of a group of proteins in the egg known as the subcortical maternal complex (SCMC). PADI6 is one of its components (review of PADI6 and early embryonic arrest, 2022). When PADI6 is missing or broken, the complex cannot do its job, and the embryo struggles to make the handoff — often arresting in the first few days.

How PADI6 variants show up

Biallelic (two-copy) variants in PADI6 were shown to cause female infertility characterized by early embryonic arrest in a foundational 2016 study, and additional variants have been described since (Xu et al., American Journal of Human Genetics, 2016). The typical picture is:

• Eggs are retrieved and fertilize.
• Embryos begin to divide, then arrest at the cleavage stage — often around days 2 to 4 — and rarely reach blastocyst.
• The pattern repeats across cycles, which is what distinguishes it from ordinary cycle-to-cycle variation.

Because PADI6 helps regulate the earliest developmental program, variants have also been associated with disturbances in genomic imprinting in some cases — another sign that this is about the foundational setup of an embryo, not its chromosome count.

How PADI6 is inherited

PADI6-related early embryonic arrest is autosomal recessive: it takes an altered copy from each parent for the effect to appear in a woman's eggs (OMIM: PADI6, 610363). Each parent is typically an unaffected carrier with no reproductive problems of their own. That is why the cause can hide until IVF reveals the repeated-arrest pattern, and why screening both partners for shared carrier status can be informative.

What testing can and cannot tell you

For repeated, unexplained early embryo arrest, identifying biallelic PADI6 variants can give a concrete reason where a chromosome-based test cannot — because the embryos may be chromosomally normal and still unable to make the genome-activation handoff. A finding can help a couple and clinician understand the pattern and consider options, which for some families includes donor eggs.

The honest limits:

• It is rare, and most early arrest is not caused by PADI6.
• A finding is not a diagnosis, and a "variant of uncertain significance" cannot be treated as an answer.
• It describes a mechanism, not a treatment; there is no fix that repairs the gene.

Where Reticular fits

PADI6 is one of the genes on Reticular's parent-only reproductive screen, alongside other subcortical-maternal-complex and embryo-viability genes. The screen reviews saliva from one or both intended parents for rare variants tied to early development and pregnancy loss, and includes genetic counseling. It is most relevant for a repeated pattern of early embryo arrest, not a single loss.

As with every gene here, the boundary matters: this is not a replacement for carrier screening, karyotyping, or embryo testing, and a finding is information to weigh with your care team rather than a diagnosis. To see how PADI6 sits among the other maternal-effect genes, read Maternal-Effect Genes: The Pregnancy-Loss Genes a Karyotype Can't See.